Renata Libianto
Clayton, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Primary Aldosteronism Medical Treatment Outcomes (PAMO) Beyond 12 Months.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: July 22, 2026
Improving primary aldosteronism diagnosis and treatment: outcomes from an endocrine hypertension service.
Journal: Internal medicine journal
Published: February 18, 2026
Prevalence, clinical characteristics and management of low-renin hypertension: a real-world cohort study.
Journal: Journal of human hypertension
Published: September 24, 2025
Beyond aldosterone and renin: emerging biomarkers for diagnosing and subtyping primary aldosteronism.
Journal: Endocrine reviews
Published: September 09, 2025
Changes in PTH Across the Spectrum of Renin-independent Aldosteronism.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 30, 2024
Response to Letter to the Editor From Spence: [Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population].
Journal: Journal of the Endocrine Society
Published: August 07, 2024
Screening for primary aldosteronism in primary care: a scoping review.
Journal: Family practice
Published: June 24, 2024
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.
Journal: The lancet. Diabetes & endocrinology
Published: May 29, 2024
Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population.
Journal: Journal of the Endocrine Society
Published: April 18, 2024
Challenges in Diagnosing and Managing the Spectrum of Primary Aldosteronism.
Journal: Journal of the Endocrine Society
Published: February 22, 2024
Improving Detection Rates for Primary Aldosteronism.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: May 09, 2023
Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension.
Journal: BMJ open
Published: November 14, 2022
Last Updated: 09/26/2026